Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2010
09/07/2010US7790753 Derivatives of N-[phenyl(alkylpiperidine-2-yl)methyl]benzamide, preparation method thereof and application of same in therapeutics
09/07/2010US7790736 Dipeptidyl peptidase inhibitors
09/07/2010US7790723 1-[3-(3-cyclopentyloxy-4-methoxyphenyl)-3,4,5,6-tetrahydropyridazin-1-yl]-1-[4-methyl-2-(1-oxypyridin-2-yl)thiazol-5-yl]methanone, used for inhibiting proliferation of lymphocytes in a host, and for the treatment of osteoporosis, tumors, cachexia, atherosclerosis, arthritis, multiple sclerosis, diabetes
09/07/2010US7790713 Inhibitors of interleukin-1β converting enzyme
09/07/2010US7790698 2-Alkoxyadeosine or 2-alkoxy-3'-deoxyadenosine where the alkoxy contains 1-4 carbon atoms; particularly 2-methoxy-adenosine (spongosine) or salt; antiinflammatory agents; side effect reduction, particularly, cardiovascular disorders such as bradycardia and tachycardia
09/07/2010US7790669 Parkinson's disease, Alzheimer's disease or Huntington's disease or a neurological injury that results from ischemia such as a stroke; tissue repair
09/07/2010US7790165 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases
09/07/2010US7790158 Using tumor necrosis factors specific immunoglobulins to treat rheumatoid arthritis, diabetes type I, multiple sclerosis, and inflammatory bowel diseases
09/07/2010CA2493680C Condensed heterocyclic pyrazole derivatives as kinase inhibitors
09/07/2010CA2492081C Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders
09/07/2010CA2485349C A11-piperazinyldibenzo (b, f) (1, 4) oxazepines and thiazepines as atypical antipsychotic agents having low affinity for the d2 receptor
09/07/2010CA2457245C Transdermal therapeutic system (tts) containing the active substance fentanyl
09/07/2010CA2454785C 4-oxoimidazolidine-2-spiropiperidine derivatives
09/07/2010CA2414774C Use of dopamine d2/d3 receptor agonists to treat fibromyalgia
09/07/2010CA2375810C Beta2-adrenoceptor agonists
09/07/2010CA2370344C Thieno- and furopyrimidine derivatives as a2a-receptor antagonists
09/07/2010CA2368814C Use of glucosylceramide synthesis inhibitors in therapy
09/02/2010WO2010099200A1 Oligomer-amino acid conjugates
09/02/2010WO2010098600A2 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
09/02/2010WO2010098502A1 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
09/02/2010WO2010098495A1 Imidazolylpyrazine derivatives
09/02/2010WO2010098490A1 Salt of tetrahydrotriazolopyridine derivative and crystal thereof
09/02/2010WO2010098344A1 Tricyclic pyrazolopyrimidine derivative
09/02/2010WO2010098298A1 Pharmaceutical composition comprising combination of compound having nutrient digestion/absorption inhibitory activity and cyclohexanecarboxamide derivative
09/02/2010WO2010098265A1 Polymeric micelle containing proteasome inhibitor
09/02/2010WO2010098261A1 Risperidone-containing transdermal preparation and adhesive patch using same
09/02/2010WO2010098230A1 Transdermal preparation
09/02/2010WO2010097703A1 Highly pure eletriptan or a pharmaceutically acceptable salt thereof substantially free of eletriptan n-oxide impurity
09/02/2010WO2010097469A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097468A1 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097467A1 N-phenylacetamide derivatives, which inhibit the enzyme soat-1 and pharmaceutical and cosmetic compositions containing them
09/02/2010WO2010097379A1 Substituted pyrimidin derivatives and their medical use
09/02/2010WO2010097373A1 Compounds for use as bradykinin b1 antagonists
09/02/2010WO2010097371A1 Ceramide-analogous metabolites
09/02/2010WO2010097368A1 Isoxazole / o-pyridine derivatives with ethyl and ethenyl linker
09/02/2010WO2010097334A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097332A1 Drug combinations containing pde4 inhibitors and nsaids
09/02/2010WO2010097092A1 Treatment of dyskinesia related disorders
09/02/2010WO2010097091A1 Methods of administering (4ar, 1oar)-i-n-propyl-i, 2,3,4a7 s1io7 ioa-octahydrobenzo [g] quinoline-6,7-diol and related compounds across the oral mucosa, the nasal mucosa or the skin and pharmaceutical compositions thereof
09/02/2010WO2010096925A1 Homotaurine-supplemented and/or enriched edible material, methods of preparation an d uses
09/02/2010WO2010080452A3 siRNA COMPOUNDS AND METHODS OF USE THEREOF
09/02/2010WO2010060073A3 Method for treating parkinson' s disease using filamentous bacteriophage
09/02/2010WO2010057028A9 Treatment of proteinopathies using a farnesyl transferase inhibitor
09/02/2010WO2010045577A3 Extracts of curcuma and methods of use thereof
09/02/2010WO2010006772A8 Use of cd95 inhibitors for the treatment of inflammatory disorders
09/02/2010WO2009114097A4 Method of modulating t cell-dependent immune responses
09/02/2010US20100223678 protein isoforms of the pif-family and uses thereof
09/02/2010US20100222576 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses
09/02/2010US20100222436 Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
09/02/2010US20100222435 Modified-release formulations of a bupropion salt
09/02/2010US20100222434 Pharmaceutical composition for inhibiting amyloid-beta protein accumulation
09/02/2010US20100222431 Novel phenylurea inhibitors of the soat-1 enzyme and pharmaceutical/cosmetic compositions comprised thereof
09/02/2010US20100222424 Method of Screening Drug with the Use of 67 kDa Laminin Receptor and Drug Obtained Thereby
09/02/2010US20100222423 Aspalathin-like dihydrochalcone, extracts from unfermented rooibos and process for preparation
09/02/2010US20100222421 Usage of Baicalein in the Preparation of a Pharmaceutical Composition for the Treatment of Traumatic Brain Injury
09/02/2010US20100222415 Method to Diagnose, Predict Treatment Response and Develop Treatment for Psychiatric Disorders Using Markers
09/02/2010US20100222408 Methods and Compositions for Treatment of Cystic Fibrosis
09/02/2010US20100222398 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
09/02/2010US20100222395 Compounds capable of activating cholinergic receptors
09/02/2010US20100222388 Enhanced Migraine Treatments Based on Ghrelin Mimetics
09/02/2010US20100222387 3-Fluoro-Piperidine T-Type Calcium Channel Antagonists
09/02/2010US20100222386 Substituted piperidines
09/02/2010US20100222378 2-heteroarylcarboxylic acid amides
09/02/2010US20100222377 Bis-quaternary ammonium cyclophane compounds that interact with neuronal nicotinic acetylcholine receptors
09/02/2010US20100222376 Chelerythrine, analogs thereof and their use in the treatment of bipolar disorder and other cognitive disorders
09/02/2010US20100222374 Spirocyclic heterocyclic derivatives and methods of their use
09/02/2010US20100222368 N-(Heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
09/02/2010US20100222366 Piperidine derivatives as modulators of chemokine receptor activity
09/02/2010US20100222365 Substituted triazole deriviatives as oxytocin antagonists
09/02/2010US20100222363 Bicyclic Derivatives as P38 Inhibitors
09/02/2010US20100222359 Compositions, synthesis, and methods of utilizing quinazolinedione derivatives
09/02/2010US20100222358 Octahydro-pyrrolo[3,4-b]pyrrole derivatives
09/02/2010US20100222355 Quinolizidinone m1 receptor positive allosteric modulators
09/02/2010US20100222354 AMPA Receptor Antagonists and Aldose Reductase Inhibitors for Neuropathic Pain
09/02/2010US20100222353 Aminophthalazine derivative compounds
09/02/2010US20100222348 Quinolinone derivatives as parp inhibitors
09/02/2010US20100222346 4-benzylaminoquinolines, pharmaceutical compositions containing them, and their use in therapy
09/02/2010US20100222339 Thiazole pyrazolopyrimidines CRF1 receptor antagonists
09/02/2010US20100222338 Beta-secretase modulators and methods of use
09/02/2010US20100222334 Pharmaceutical Formulation of Valsartan
09/02/2010US20100222332 Pyrazolo-pyrazines derivatives used as g protein inhibitors
09/02/2010US20100222330 New Compounds
09/02/2010US20100222327 Methods of Preparing Pharmaceutical Compositions Comprising Eslicarbazepine Acetate and Methods of Use
09/02/2010US20100222326 New Heterocyclic Derivatives Useful For The Treatment of CNS Disorders
09/02/2010US20100222320 Triazole derivatives for treating alzheimer's disease and related conditions
09/02/2010US20100222317 Azetidine Derivatives as GlyT1 Inhibitors
09/02/2010US20100222316 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
09/02/2010US20100222311 Solid formulations of crystalline compounds
09/02/2010US20100222304 Methods of Treating Neuropathic Pain by Modulation of Glycogenolysis or Glycolysis
09/02/2010US20100222300 A2B Adenosine Receptor Antagonists
09/02/2010US20100222298 Spill resistant formulations containing clays
09/02/2010US20100222296 Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
09/02/2010US20100222286 Receptor modulators exhibiting neuroprotective and memory enhancing activities
09/02/2010US20100222274 Glycosylation-deficient hepatocyte growth factor
09/02/2010US20100222262 Substituted 1, 3-cyclopentadione attenuated endothelial inflammation and endothelial-monocyte interactions
09/02/2010US20100222261 Peptidic antagonists of class iii semaphorins/neuropilins complexes
09/02/2010US20100222258 TNF antagonist and TNF inhibitor containing it as an effective ingredient
09/02/2010US20100222257 Substituted phenethylamines
09/02/2010US20100221761 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using elisa assays
09/02/2010US20100221366 Composition For Prevention And Treatment Of Alzheimer's Disease
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 1833